ERG and FLI1 protein expression in epithelioid sarcoma

Modern Pathology

Volumn 27, Issue 4, 2014, Pages 496-501

  Stockman, David L ^a   Hornick, Jason L ^b   Deavers, Michael T ^a   Lev, Dina C ^a   Lazar, Alexander J ^a   Wang, Wei Lien ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

epithelioid sarcoma; ERG; FLI1

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; KERATIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D2-40; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR FLI 1; TUMOR MARKER; ERG PROTEIN, HUMAN; FLI1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; DIFFERENTIAL DIAGNOSIS; EPITHELIOID SARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RARE DISEASE; RELIABILITY; TISSUE MICROARRAY; VASCULAR TUMOR; ANTIBODY SPECIFICITY; CHEMISTRY; CROSS REACTION; DIAGNOSTIC USE; IMMUNOLOGY; PATHOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; SARCOMA;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIBODY SPECIFICITY; ANTIGENS, CD31; ANTIGENS, CD34; CELL NUCLEUS; CROSS REACTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEIN C-FLI-1; REPRODUCIBILITY OF RESULTS; SARCOMA; TISSUE ARRAY ANALYSIS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84897568981     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.161     Document Type: Article

References (21)

1. McKay KM, Doyle LA, Lazar AJ, et al. Expression of ERG, an ETS family transcription factor, distinguishes cutaneous angiosarcoma from histological mimics. Histopathology 2012;61:989-991.
2. Folpe AL, Chand EM, Goldblum JR, et al. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol 2001;25:1061-1066.
3. Miettinen M, Wang ZF, Paetau A, et al. ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma. Am J Surg Pathol 2011;35:432-441.
4. Yaskiv O, Rubin BP, He H, et al. ERG protein expression in human tumors detected with a rabbit monoclonal antibody. Am J Clin Pathol 2012;138:803-810.
5. Sakharpe A, Lahat G, Gulamhusein T, et al. Epithelioid sarcoma and unclassified sarcoma with epithelioid features: clinicopathological variables, molecular markers, and a new experimental model. Oncologist 2011;16:512-522.
6. von Hochstetter AR, Grant JW, Meyer VE, et al. Angiomatoid variant of epithelioid sarcoma. The value of immunohistochemistry in the differential diagnosis. Chir Organi Mov 1990;75:158-162.
7. von Hochstetter AR, Meyer VE, Grant JW, et al. Epithelioid sarcoma mimicking angiosarcoma: the value of immunohistochemistry in the differential diagnosis. Virchows Arch A Pathol Anat Histopathol 1991;418:271-278.
8. Wick MR, Manivel JC. Epithelioid sarcoma and epithelioid hemangioendothelioma: an immunocytochemical and lectin-histochemical comparison. Virchows Arch A Pathol Anat Histopathol 1987;410:309-316.
9. Chase DR, Enzinger FM. Epithelioid sarcoma. Diagnosis, prognostic indicators, and treatment. Am J Surg Pathol 1985;9:241-263.
10. Mills SE, Fechner RE, Bruns DE, et al. Intermediate filaments in eosinophilic cells of epithelioid sarcoma: a light-microscopic, ultrastructural, and electrophoretic study. Am J Surg Pathol 1981;5:195-202.
11. Fletcher CD, Beham A, Bekir S, et al. Epithelioid angiosarcoma of deep soft tissue: a distinctive tumor readily mistaken for an epithelial neoplasm. Am J Surg Pathol 1991;15:915-924.
12. Chase DR, Enzinger FM, Weiss SW, et al. Keratin in epithelioid sarcoma. An immunohistochemical study. Am J Surg Pathol 1984;8:435-441.
13. Arber DA, Kandalaft PL, Mehta P, et al. Vimentinnegative epithelioid sarcoma. The value of an immunohistochemical panel that includes CD34. Am J Surg Pathol 1993;17:302-307.
14. Hornick JL, Dal Cin P, Fletcher CD. Loss of SMARCB1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol 2009;33:542-550.
15. Hollmann TJ, Hornick JL. SMARCB1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol 2011;35:e47-e63.
16. Sullivan LM, Folpe AL, Pawel BR, et al. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions. Mod Pathol 2013;26:385-392.
17. Arvand A, Denny CT. Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 2001;20: 5747-5754.
18. Lushnikova T, Knuutila S, Miettinen M. DNA copy number changes in epithelioid sarcoma and its variants: a comparative genomic hybridization study. Mod Pathol 2000;13:1092-1096.
19. Wang WL, Patel NR, Caragea M, et al. Expression of ERG, an ETS family transcription factor, identifies ERG-rearranged Ewing sarcoma. Mod Pathol 2012;25:1378-1383.
20. Martens JH. Acute myeloid leukemia: a central role for the ETS factor ERG. Int J Biochem Cell Biol 2011;43:1413-1416.
21. Miettinen M, Wang Z, Sarlomo-Rikala M, et al. ERG Expression in Epithelioid Sarcoma. Am J Surg Pathol 2013;37:1580-1585.